Pharmacokinetics of oral triazolam in children

Journal of Clinical Psychopharmacology

Volumn 17, Issue 3, 1997, Pages 169-172

  Karl, Helen W ^a   Milgrom, Peter ^a   Domoto, Peter ^a   Kharasch, Evan D ^a   Coldwell, Susan E ^a   Weinstein, Philip ^a   Leroux, Brian ^a   Awamura, Kyoko ^a   Mautz, Douglas ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; LIDOCAINE; NITROUS OXIDE; TRIAZOLAM;

ARTICLE; CHILD; CLINICAL ARTICLE; COMPARTMENT MODEL; DENTAL CARE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PEDIATRICS; PRIORITY JOURNAL; SEDATION; SUSPENSION;

BIOLOGICAL AVAILABILITY; CHILD; DENTAL CARE FOR CHILDREN; FEMALE; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; METABOLIC CLEARANCE RATE; STOMATOGNATHIC DISEASES; TRIAZOLAM;

EID: 0030992219     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199706000-00005     Document Type: Article

References (11)

1. Quarnstrom FC, Milgrom P, Moore PA. Experience with triazolam in preschool children. Anesth Pain Control Dent 1992;1: 157-9.
2. Meyer ML, Mourino AP, Farrington FH. Comparison of triazolam to a chloral hydrate/hydroxyzine combination in the sedation of pediatric dental patients. Pediatr Dent 1990;12:285-7.
3. Lindstrom MJ, Bates DM. Nonlinear mixed effects models for repeated measures data. Biometrics 1990;46:673-87.
4. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. 4th ed. Philadelphia: Lea & Febiger, 1991.
5. Friedman H, Greenblatt DJ, Burstein ES, Harmatz JS, Shader RI. Population study of triazolam pharmacokinetics. Br J Clin Pharmacol 1986;22:639-42.
6. Kroboth PD, McAuley JW, Kroboth FJ, Bertz RJ, Smith RB. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration. J Clin Psychopharmacol 1995;15:259-62.
7. Friis-Hansen B. Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics 1971;47[suppl 2]:264+.
8. Depner K, Coldwell S, Awamura K, Preston K, Milgrom P. Visual effects of triazolam in children [abstract 2081]. Paper presented at the International Association for Dental Research, San Francisco, 1996.
9. Awamura K, Coldwell S, Depner K, Milgrom P, Domoto P. Memory effects of triazolam in children [abstract 1998]. Paper presented at the International Association for Dental Research, San Francisco, 1996.
10. Coté CJ. Sedation for the pediatric patient. A review. Pediatr Clin North Am 1994;41:31-58.
11. American Academy of Pediatrics (AAP). Committee on Drugs. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992;89:1110-5.